Eli Lilly and Company and Walmart have announced a partnership to offer Zepbound single-dose vials at Walmart pharmacies. The move will start nationwide in mid-November and will have direct-to-consumer pricing through LillyDirect.
This will be the first time patients using LillyDirect can access self-pay pricing for Zepbound vials at a retail pharmacy location, offering a 50% or greater discount compared to the list price of other similar obesity medicines, Eli Lilly said in a news release.
Zepbound vials will be available in all approved strengths, with the lowest dose starting at $349 per month with self-pay.
Customers can choose between free home delivery from LillyDirect or pick-up at Walmart Pharmacy. The price for Zepbound single-dose vials is the same for both options.
Zepbound is an injectable prescription medicine that may help adults with obesity or overweight who have weight-related medical problems to lose excess body weight and keep it off. It is used with a reduced-calorie diet and increased physical activity, the company said.
©2025 Cox Media Group
Sign Up
